| Dr Leila Ali-akbarian, MD,MPH | |
|
707 N Alvernon Way, Suite 101, Tucson, AZ 85711-1827 | |
| (520) 694-1611 | |
| (520) 694-1640 |
| Full Name | Dr Leila Ali-akbarian |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 18 Years |
| Location | 707 N Alvernon Way, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134307903 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 42283 (Arizona) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Banyan Integrative Health Llc | 4587904594 | 3 |
News Archive
Skilled Healthcare Group, Inc. (NYSE: SKH) today announced the funding of its first loans insured by the U.S. Department of Housing and Urban Development (HUD). The loans have a combined principal balance of $21.6 million and are secured by three skilled nursing facilities.
According to a new report, by the year 2050 as many as 730,000 Australians will be suffering from some form of dementia and almost three quarters of Australians say if such a test existed to show if they were going to develop some form of dementia, they would take it.
Meanwhile, a coalition including business interests, state officials and educational institutions is gelling around efforts to fight the health law's contraception mandate.
Two studies look at the burden posed by health care costs, both to the federal government and to households across America.
Milo Biotechnology today announced its AAV1-FS344 has been granted Orphan Drug designation from the FDA's Office of Orphan Products Development for treatment of Becker and Duchenne muscular dystrophy. AAV1-FS344 is a gene therapy-delivered myostatin inhibitor that increases muscle strength.
› Verified 3 days ago
| Entity Name | Banyan Integrative Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992262810 PECOS PAC ID: 4587904594 Enrollment ID: O20190328001522 |
News Archive
Skilled Healthcare Group, Inc. (NYSE: SKH) today announced the funding of its first loans insured by the U.S. Department of Housing and Urban Development (HUD). The loans have a combined principal balance of $21.6 million and are secured by three skilled nursing facilities.
According to a new report, by the year 2050 as many as 730,000 Australians will be suffering from some form of dementia and almost three quarters of Australians say if such a test existed to show if they were going to develop some form of dementia, they would take it.
Meanwhile, a coalition including business interests, state officials and educational institutions is gelling around efforts to fight the health law's contraception mandate.
Two studies look at the burden posed by health care costs, both to the federal government and to households across America.
Milo Biotechnology today announced its AAV1-FS344 has been granted Orphan Drug designation from the FDA's Office of Orphan Products Development for treatment of Becker and Duchenne muscular dystrophy. AAV1-FS344 is a gene therapy-delivered myostatin inhibitor that increases muscle strength.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Leila Ali-akbarian, MD,MPH 2802 N Alvernon Way Ste 200, Tucson, AZ 85712-1500 Ph: (520) 326-0850 | Dr Leila Ali-akbarian, MD,MPH 707 N Alvernon Way, Suite 101, Tucson, AZ 85711-1827 Ph: (520) 694-1611 |
News Archive
Skilled Healthcare Group, Inc. (NYSE: SKH) today announced the funding of its first loans insured by the U.S. Department of Housing and Urban Development (HUD). The loans have a combined principal balance of $21.6 million and are secured by three skilled nursing facilities.
According to a new report, by the year 2050 as many as 730,000 Australians will be suffering from some form of dementia and almost three quarters of Australians say if such a test existed to show if they were going to develop some form of dementia, they would take it.
Meanwhile, a coalition including business interests, state officials and educational institutions is gelling around efforts to fight the health law's contraception mandate.
Two studies look at the burden posed by health care costs, both to the federal government and to households across America.
Milo Biotechnology today announced its AAV1-FS344 has been granted Orphan Drug designation from the FDA's Office of Orphan Products Development for treatment of Becker and Duchenne muscular dystrophy. AAV1-FS344 is a gene therapy-delivered myostatin inhibitor that increases muscle strength.
› Verified 3 days ago
Dr. Jeffrey T. Mack, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 4001 E Sunrise Dr Ste 161, Tucson, AZ 85718 Phone: 520-408-6955 | |
Melissa Laura Ray, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2155 W Orange Grove Rd, Tucson, AZ 85741 Phone: 520-742-0414 Fax: 520-742-4063 | |
David L Massanari, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3945 E Paradise Falls Drive, Ste 201, Tucson, AZ 85712 Phone: 520-615-6200 Fax: 520-615-6255 | |
Violet P Siwik, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 707 N Alvernon Way Ste 101, Tucson, AZ 85711 Phone: 520-694-8888 Fax: 520-694-1640 | |
Dr. Ivy L Schwartz, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2502 N Dodge Blvd, Suite 100, Tucson, AZ 85716 Phone: 520-618-8747 Fax: 520-882-5676 | |
Rhema Sayers, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 N Wilmot Rd, Suite 110, Tucson, AZ 85712 Phone: 520-884-4999 Fax: 520-300-6669 | |
Dr. Shauna Lee Mcisaac, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3550 N First Ave, Suite 300, Tucson, AZ 85719 Phone: 520-887-0715 Fax: 520-887-1315 |